# HIV Reservoir Dynamics After Switching to Dolutegravir in Patients on a PI and 2 NRTI Based Regimen

> **NCT02513147** · PHASE4 · COMPLETED · sponsor: **Hospital Universitari Vall d'Hebron Research Institute** · enrollment: 44 (actual)

## Conditions studied

- HIV-1

## Interventions

- **DRUG:** Dolutegravir
- **DRUG:** PI
- **DRUG:** 2 NRTI
- **DRUG:** 2 NRTI

## Key facts

- **NCT ID:** NCT02513147
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2017-06-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02513147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02513147, "HIV Reservoir Dynamics After Switching to Dolutegravir in Patients on a PI and 2 NRTI Based Regimen". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02513147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*